For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
PLGA (poly (lactic-co-glycolic acid)) is a unique base polymer for controlled release of drugs and medical implant materials. It is both biodegradable and biocompatible, and since both monomers occur naturally it has minimal toxicity. PLGA is naturally amorphous (not crystalline).
Scope of the Report:
Currently, a few companies in the world can produce PLGA product, mainly concentrating in Europe and China. The main market players are Evonik, PCAS, Corbion, Mitsui Chemicals, SDSYXS, Jinan Daigang Biomaterial, etc.
In consumption market, the growth rate of global consumption is smooth relatively. Europe, China and USA are still the mainly consumption regions due to the advanced production technology and rapid development of economy.
PLGA is biocompatible and biodegradable, exhibits a wide range of erosion times, has tunable mechanical properties and most importantly, is a FDA approved polymer. Currently, a majority of manufacturers can offer microspheres comprised of four standard PLGA polymer ratios (50:50, 65:35, 75:25 and 85:15 Lactic Acid: Glycolic Acid). FDA has approved PLGA for micro and nano particles and for a number of therapeutic devices such as grafts, sutures, implants and prosthetic devices. With the development of economy, these industries will need more PLGA. So, PLGA has a huge market potential in the future.
The worldwide market for PLGA is expected to grow at a CAGR of roughly 13.0% over the next five years, will reach 91 million US$ in 2024, from 44 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the PLGA in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Evonik
- PCAS
- Corbion
- Mitsui Chemicals
- SDSYXS
- Jinan Daigang Biomaterial
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- PLGA 50:50
- PLGA 65:35
- PLGA 75:25
- PLGA 85:15
- Other
Market Segment by Applications, can be divided into
- Suture
- Fracture Fixation
- Oral Implant
- Drug Delivery Microsphere
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PLGA product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PLGA, with price, sales, revenue and global market share of PLGA in 2017 and 2018.
Chapter 3, the PLGA competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PLGA breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, PLGA market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe PLGA sales channel, distributors, customers, research findings and conclusion, appendix and data source.